Literature DB >> 15210767

An IL-12-independent role for CD40-CD154 in mediating effector responses: studies in cell-mediated glomerulonephritis and dermal delayed-type hypersensitivity.

Amanda-Jane Ruth1, A Richard Kitching, Ming Li, Timothy J Semple, Jennifer R Timoshanko, Peter G Tipping, Stephen R Holdsworth.   

Abstract

Crescentic glomerulonephritis (GN) results from IL-12-driven Th1-directed cell-mediated responses (akin to delayed-type hypersensitivity (DTH)) directed against glomerular Ags. CD40-CD154 interactions are critical for IL-12 production and Th1 polarization of immune responses. Crescentic anti-glomerular basement membrane GN was induced in C57BL/6 (wild-type (WT)) mice (sensitized to sheep globulin) by planting this Ag (as sheep anti-mouse glomerular basement membrane globulin) in their glomeruli. Crescentic GN did not develop in CD40(-/-) mice due to significantly reduced nephritogenic Th1 responses. IL-12 was administered to CD40(-/-) mice with GN to dissect interactions between IL-12 and CD40 in inducing nephritogenic immunity and injury. Administration of IL-12 to CD40(-/-) mice restored Th cell IFN-gamma production, and up-regulated intrarenal chemokines and glomerular T cell and macrophage accumulation compared with WT control mice. Despite this, renal macrophages were not activated and renal injury and dermal DTH were not restored. Thus, CD40-directed IL-12 drives Th1 generation and effector cell recruitment but CD40 is required for activation. To test this hypothesis, activated OT-II OVA-specific CD4(+) cells and OVA(323-339)-loaded nonresponsive APCs were transferred into footpads of WT, CD40(-/-), and macrophage-depleted WT mice. WT mice developed significant DTH compared with CD40(-/-) and macrophage-depleted WT mice. This study demonstrated that CD40-induced IL-12 is required for generation of systemic Th1 immunity to nephritogenic Ags, and that IL-12 enhances Th1 effector cell recruitment to peripheral sites of Ag presentation via generation of local chemokines. Effector cell activation, renal DTH-like injury, and dermal DTH require direct Th1 CD154/macrophage CD40 interactions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210767     DOI: 10.4049/jimmunol.173.1.136

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Kidney Dendritic Cells Become Pathogenic during Crescentic Glomerulonephritis with Proteinuria.

Authors:  Katharina Hochheiser; Daniel R Engel; Linda Hammerich; Felix Heymann; Percy A Knolle; Ulf Panzer; Christian Kurts
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

Review 2.  Glomerulonephritis, Th1 and Th2: what's new?

Authors:  P G Tipping; A R Kitching
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

3.  IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen.

Authors:  Joshua D Ooi; Richard K S Phoon; Stephen R Holdsworth; A Richard Kitching
Journal:  J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 10.121

4.  In the absence of CD154, administration of interleukin-12 restores Th1 responses but not protective immunity to Schistosoma mansoni.

Authors:  James P Hewitson; Paul A Hamblin; Adrian P Mountford
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

5.  T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis.

Authors:  Richard K S Phoon; A Richard Kitching; Dragana Odobasic; Lynelle K Jones; Timothy J Semple; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

Review 6.  Biologics for the treatment of autoimmune renal diseases.

Authors:  Stephen R Holdsworth; Poh-Yi Gan; A Richard Kitching
Journal:  Nat Rev Nephrol       Date:  2016-03-07       Impact factor: 28.314

7.  Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis.

Authors:  Ming Li; Kim M O'Sullivan; Lynelle K Jones; Cecilia Lo; Timothy Semple; Atsushi Kumanogoh; Hitoshi Kikutani; Stephen R Holdsworth; Richard Kitching
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

8.  The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis.

Authors:  Hans-Joachim Paust; Jan-Eric Turner; Oliver M Steinmetz; Anett Peters; Felix Heymann; Christoph Hölscher; Gunter Wolf; Christian Kurts; Hans-Willi Mittrücker; Rolf A K Stahl; Ulf Panzer
Journal:  J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 10.121

9.  Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1).

Authors:  Marion Hückel; Uta Schurigt; Andreas H Wagner; Renate Stöckigt; Peter K Petrow; Klaus Thoss; Mieczyslaw Gajda; Steffen Henzgen; Markus Hecker; Rolf Bräuer
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.